The state of Oregon currently has 265 active clinical trials seeking participants for Cancer research studies. These trials are conducted in various cities, including Portland, Eugene, Medford and Clackamas.
Intra-arterial Gemcitabine vs. IV Gemcitabine and Nab-Paclitaxel Following Radiotherapy for LAPC
Recruiting
The study is a multi-center, un-blinded, randomized control study of subjects with locally advanced pancreatic adenocarcinoma which is unresectable.
Gender:
All
Ages:
18 years and above
Trial Updated:
02/23/2022
Locations: Oregon Health & Science University, Portland, Oregon
Conditions: Locally Advanced Pancreatic Cancer